Lilly Corporate Ctr, Drop Code 1094, Indianapolis, IN
Summary
The estimated value of insider holdings of ELI LILLY & Co is at least $1.49K dollars as of August 14, 2023. ELI LILLY & Co is the 10%+ Owner of Sigilon Therapeutics, Inc. and owns shares of Sigilon Therapeutics, Inc. stock worth about $1.49K.
Signature
/s/ Anat Ashkenazi, Executive Vice President and Chief Financial Officer, on behalf of Eli Lilly and Company
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.